Overview A Study of SHR-1501 in Patients With Advanced Tumors Status: Recruiting Trial end date: 2021-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the safety and tolerability of SHR-1501 in patients with advanced malignancies . Phase: Phase 1 Details Lead Sponsor: Jiangsu HengRui Medicine Co., Ltd.